Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Gallo: FLSC Phase I & II Clinical Trials |
| Strategy: | Protein & peptide vaccines |
| Study Type: | Phase I |
| Species: | Human |
| Stage: | Assays complete |
| Study Start Date: | 2015-02-11 |
| Study Made Public: | 2020-01-29 |
Title
FLSC Phase I Clinical Trial
Description
CAVD 477 is a Phase I, placebo-controlled, clinical trial comparing increasing doses of the full-length single-chain (FLSC) immunogen in alum.
Sign in to see full information about this study and to download study data.
Products
FLSC Alum Saline (non-specific)Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.